As the clear lens slowly colons with age, your vision gradually may acquire a brownish shade. The rest of this article focuses just on age-related cataracts. It cannot spread from one eye to the other. Floaters are little “cobwebs” or specks that seem to float about in your field of vision. Cataracts may develop in only one eye, but they usually develop in both of your eyes. This outpatient procedure is called a MAG laser capsulotomy. Extracapsular surgery involves removing the cloudy part of the lens through a long incision in the cornea. Cataracts are sometimes linked to steroid use. A Closer Look At Strategies Of Cataracts – Guidance To The View
Dr. Shruti Sharma of the Center for Biotechnology and Genomic Medicine has a $1.5 million grant from the National Eye Institute to look at basic research into blocking inflammation among epithelial cells in light-sensing retina in the eye, Sharma is looking at a well-known agent in inflammation called interleukin-6 that can affect those cells even though they lack the receptor normally needed for such interaction, an effect called trans-signaling. While that effect had been known for a while it is not something that researchers had focused on in the past, she said. Sharma is looking at an experimental drug that in her early work seems to have blocked that type of action in those cells, using it both in the lab in human cells in the same kind of environment that is there in the eye and in a mouse model of diabetes. The hope is to prevent the barrier disruption to the cells that can cause them to become leaky and create inflammation, an early hallmark of the disease. The mouse model allows Sharma to test the compound in both late and early stages of the disease to see if it she can prevent diabetic retinopathy from happening, she said. http://experteyedoc.macsverige.org/2016/12/05/some-growing-options-for-speedy-solutions-for-laser-eye-surgery/Separately, the compound is being tested in human clinical trials in rheumatoid arthritis, which is also promising, Sharma said. Im more excited because I am re-purposing this drug, she said. I am not trying to develop a new drug. But that potential is why Augusta University has translational programs to try and bring those promising research ideas to the clinic, said Nussbaum , chair of the Department of Ophthalmology. And it is a big problem to address – there are at least 4.2 million people with diabetic retinopathy in the U.S., according to the American Diabetes Association.
For the original version including any supplementary images or video, visit http://www.washingtontimes.com/news/2017/jan/1/new-drug-might-help-with-diabetes-related-blindnes/?utm_source=RSS_Feed&utm_medium=RSS